Abstract
The large randomized study by Crook et al. demonstrated that intermittent administration of androgen deprivation therapy should be considered the standard of care when patients with moderate and well-differentiated localized prostate cancer are treated for rising PSA levels after definitive radiotherapy.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have